{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:53:37Z","timestamp":1794012817273,"version":"4.8.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["4162"],"award-info":[{"award-number":["4162"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["118Z791"],"award-info":[{"award-number":["118Z791"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["118C014"],"award-info":[{"award-number":["118C014"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.xcrm.2024.101498","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T01:07:25Z","timestamp":1712192845000},"page":"101498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Oncostatin M signaling drives cancer-associated skeletal muscle wasting"],"prefix":"10.1016","volume":"5","author":[{"given":"Aylin","family":"Domaniku-Waraich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samet","family":"Agca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batu","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melis","family":"Sucuoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi D\u00f6nd\u00fc","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevval Nur","family":"Bilgic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilsad Hilal","family":"Arabaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aynur Erkin","family":"Kashgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8722-9913","authenticated-orcid":false,"given":"Serkan","family":"Kir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101498_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2024.101498_bib2","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2024.101498_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Argil\u00e9s","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.xcrm.2024.101498_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","article-title":"Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management","volume":"20","author":"Argil\u00e9s","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101498_bib5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/jcsm.12633","article-title":"Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?","volume":"11","author":"Dolly","year":"2020","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.xcrm.2024.101498_bib6","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","article-title":"Cachexia: A systemic consequence of progressive, unresolved disease","volume":"186","author":"Ferrer","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101498_bib7","doi-asserted-by":"crossref","first-page":"597675","DOI":"10.3389\/fphys.2020.597675","article-title":"Inflammation and Skeletal Muscle Wasting During Cachexia","volume":"11","author":"Webster","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.xcrm.2024.101498_bib8","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/cncr.22944","article-title":"A placebo-controlled double blind trial of etanercept for the cancer anorexia\/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group","volume":"110","author":"Jatoi","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2024.101498_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung cancer"},{"key":"10.1016\/j.xcrm.2024.101498_bib10","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101498_bib11","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer","volume":"11","author":"Bayliss","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.xcrm.2024.101498_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fonc.2020.00298","article-title":"Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options","volume":"10","author":"Marceca","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2024.101498_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cytogfr.2015.07.006","article-title":"Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology","volume":"26","author":"Hermanns","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.xcrm.2024.101498_bib14","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.83.24.9739","article-title":"Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells","volume":"83","author":"Zarling","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101498_bib15","doi-asserted-by":"crossref","first-page":"512103","DOI":"10.1155\/2013\/512103","article-title":"The enigmatic cytokine oncostatin m and roles in disease","volume":"2013","author":"Richards","year":"2013","journal-title":"ISRN Inflamm."},{"key":"10.1016\/j.xcrm.2024.101498_bib16","doi-asserted-by":"crossref","first-page":"47038","DOI":"10.1074\/jbc.M107971200","article-title":"Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms","volume":"276","author":"Blanchard","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101498_bib17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/oby.22254","article-title":"Adipose Tissue Dysfunction Occurs Independently of Obesity in Adipocyte-Specific Oncostatin Receptor Knockout Mice","volume":"26","author":"Stephens","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.xcrm.2024.101498_bib18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41586-023-06047-y","article-title":"EDA2R-NIK signalling promotes muscle atrophy linked to cancer cachexia","volume":"617","author":"Bilgic","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101498_bib19","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2024.101498_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101498_bib21","doi-asserted-by":"crossref","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Bonetto","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101498_bib22","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1074\/jbc.M115.641514","article-title":"Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia","volume":"290","author":"Silva","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101498_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1471-4159.2000.0750563.x","article-title":"Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1\/2 and p38","volume":"75","author":"Van Wagoner","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.xcrm.2024.101498_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1189\/jlb.3MR0117-033R","article-title":"The IL-31\/IL-31 receptor axis: general features and role in tumor microenvironment","volume":"102","author":"Ferretti","year":"2017","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2024.101498_bib25","doi-asserted-by":"crossref","first-page":"pky043","DOI":"10.1093\/jncics\/pky043","article-title":"Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival","volume":"2","author":"Judge","year":"2018","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.xcrm.2024.101498_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1083\/jcb.201402079","article-title":"Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy","volume":"207","author":"Dadgar","year":"2014","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.xcrm.2024.101498_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10048-003-0148-x","article-title":"Gene expression profiling of Duchenne muscular dystrophy skeletal muscle","volume":"4","author":"Haslett","year":"2003","journal-title":"Neurogenetics"},{"key":"10.1016\/j.xcrm.2024.101498_bib28","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/hmg\/ddy364","article-title":"MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD","volume":"28","author":"Wang","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xcrm.2024.101498_bib29","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/hmg\/ddaa031","article-title":"Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsies","volume":"29","author":"Wong","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xcrm.2024.101498_bib30","doi-asserted-by":"crossref","first-page":"R393","DOI":"10.1152\/ajpregu.00716.2007","article-title":"Interleukin-6 and cachexia in ApcMin\/+ mice","volume":"294","author":"Baltgalvis","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.xcrm.2024.101498_bib31","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/bjc.1996.294","article-title":"The relationship between weight loss and interleukin 6 in non-small-cell lung cancer","volume":"73","author":"Scott","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2024.101498_bib32","doi-asserted-by":"crossref","first-page":"e102436","DOI":"10.1371\/journal.pone.0102436","article-title":"Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer","volume":"9","author":"Ando","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101498_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1172\/JCI118398","article-title":"Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice","volume":"97","author":"Tsujinaka","year":"1996","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101498_bib34","doi-asserted-by":"crossref","first-page":"e24650","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse","volume":"6","author":"White","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101498_bib35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/(SICI)1097-0215(19961127)68:5<637::AID-IJC14>3.0.CO;2-Z","article-title":"Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways","volume":"68","author":"Fujita","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2024.101498_bib36","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1038\/onc.2016.437","article-title":"Blockade of the IL-6 trans-signalling\/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma","volume":"36","author":"Miller","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2024.101498_bib37","doi-asserted-by":"crossref","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","article-title":"A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia","volume":"290","author":"Seto","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101498_bib38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/s12935-021-02332-w","article-title":"Downregulation of miR-29c promotes muscle wasting by modulating the activity of leukemia inhibitory factor in lung cancer cachexia","volume":"21","author":"Xie","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.xcrm.2024.101498_bib39","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/cr.2010.144","article-title":"Oncostatin M inhibits myoblast differentiation and regulates muscle regeneration","volume":"21","author":"Xiao","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2024.101498_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.bbrc.2019.06.143","article-title":"Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation","volume":"516","author":"Miki","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2024.101498_bib41","doi-asserted-by":"crossref","first-page":"155972","DOI":"10.1016\/j.cyto.2022.155972","article-title":"Exogenous Oncostatin M induces Cardiac Dysfunction, Musculoskeletal Atrophy, and Fibrosis","volume":"159","author":"Jengelley","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.xcrm.2024.101498_bib42","doi-asserted-by":"crossref","first-page":"739918","DOI":"10.3389\/fimmu.2021.739918","article-title":"Metallothionein 1: A New Spotlight on Inflammatory Diseases","volume":"12","author":"Dai","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2024.101498_bib43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/biomedicines11010156","article-title":"SERPINA3: Stimulator or Inhibitor of Pathological Changes","volume":"11","author":"de Mezer","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.xcrm.2024.101498_bib44","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/hmg\/ddw005","article-title":"Genetic overexpression of Serpina3n attenuates muscular dystrophy in mice","volume":"25","author":"Tjondrokoesoemo","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xcrm.2024.101498_bib45","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jcsm.12315","article-title":"Increased Serpina3n release into circulation during glucocorticoid-mediated muscle atrophy","volume":"9","author":"Gueugneau","year":"2018","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.xcrm.2024.101498_bib46","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1152\/physiolgenomics.00128.2014","article-title":"Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia","volume":"47","author":"Shum","year":"2015","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.xcrm.2024.101498_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/ijms21010088","article-title":"Increased Adenine Nucleotide Degradation in Skeletal Muscle Atrophy","volume":"21","author":"Miller","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2024.101498_bib48","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1113\/JP273097","article-title":"FoxO-dependent atrogenes vary among catabolic conditions and play a key role in muscle atrophy induced by hindlimb suspension","volume":"595","author":"Brocca","year":"2017","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.xcrm.2024.101498_bib49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/MCB.01036-12","article-title":"Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia","volume":"33","author":"Ibebunjo","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2024.101498_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"Lecker","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.xcrm.2024.101498_bib51","doi-asserted-by":"crossref","first-page":"154864","DOI":"10.1016\/j.metabol.2021.154864","article-title":"AMP deamination is sufficient to replicate an atrophy-like metabolic phenotype in skeletal muscle","volume":"123","author":"Miller","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.xcrm.2024.101498_bib52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jtemb.2007.09.011","article-title":"Metallothionein functions and structural characteristics","volume":"21","author":"Carpen\u00e8","year":"2007","journal-title":"J.\u00a0Trace Elem. Med. Biol."},{"key":"10.1016\/j.xcrm.2024.101498_bib53","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1152\/japplphysiol.00180.2006","article-title":"Analysis of human skeletal muscle after 48\u00a0h immobilization reveals alterations in mRNA and protein for extracellular matrix components","volume":"101","author":"Urso","year":"2006","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.xcrm.2024.101498_bib54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1113\/jphysiol.2006.118042","article-title":"Alterations in mRNA expression and protein products following spinal cord injury in humans","volume":"579","author":"Urso","year":"2007","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.xcrm.2024.101498_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00305-16","article-title":"Blockade of Metallothioneins 1 and 2 Increases Skeletal Muscle Mass and Strength","volume":"37","author":"Summermatter","year":"2017","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2024.101498_bib56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10974-013-9350-0","article-title":"Increased sarcolipin expression and decreased sarco(endo)plasmic reticulum Ca2+ uptake in skeletal muscles of mouse models of Duchenne muscular dystrophy","volume":"34","author":"Schneider","year":"2013","journal-title":"J.\u00a0Muscle Res. Cell Motil."},{"key":"10.1016\/j.xcrm.2024.101498_bib57","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41467-017-01146-7","article-title":"Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice","volume":"8","author":"Voit","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101498_bib58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13046-016-0317-z","article-title":"Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting","volume":"35","author":"Huang","year":"2016","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101498_bib59","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/jcsm.12699","article-title":"Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting","volume":"12","author":"Cole","year":"2021","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.xcrm.2024.101498_bib60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jcp.20278","article-title":"Expression and activity of C\/EBPbeta and delta are upregulated by dexamethasone in skeletal muscle","volume":"204","author":"Yang","year":"2005","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.xcrm.2024.101498_bib61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/mus.23893","article-title":"A differential pattern of gene expression in skeletal muscle of tumor-bearing rats reveals dysregulation of excitation-contraction coupling together with additional muscle alterations","volume":"49","author":"Fontes-Oliveira","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.xcrm.2024.101498_bib62","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","article-title":"Stat3 activation links a C\/EBPdelta to myostatin pathway to stimulate loss of muscle mass","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2024.101498_bib63","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.tips.2023.07.006","article-title":"Muscle wasting: emerging pathways and potential drug targets","volume":"44","author":"Domaniku","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.xcrm.2024.101498_bib64","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2024.101498_bib65","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s41467-018-03876-8","article-title":"Induction of muscle stem cell quiescence by the secreted niche factor Oncostatin M","volume":"9","author":"Sampath","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101498_bib66","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.stemcr.2017.10.027","article-title":"Coupling between Myogenesis and Angiogenesis during Skeletal Muscle Regeneration Is Stimulated by Restorative Macrophages","volume":"9","author":"Latroche","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101498_bib67","doi-asserted-by":"crossref","first-page":"21703","DOI":"10.1074\/jbc.M116.748483","article-title":"Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass","volume":"291","author":"Walker","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101498_bib68","doi-asserted-by":"crossref","first-page":"eabh3693","DOI":"10.1126\/sciadv.abh3693","article-title":"Anti-inflammatory nanoparticles significantly improve muscle function in a murine model of advanced muscular dystrophy","volume":"7","author":"Raimondo","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2024.101498_bib69","doi-asserted-by":"crossref","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2024.101498_bib70","first-page":"Unit13.4","article-title":"Gene delivery to muscle. Curr Protoc Hum Genet Chapter","volume":"Chapter 13","author":"Springer","year":"2002","journal-title":"Curr. Protoc. Hum. Genet."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124001666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124001666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T13:50:27Z","timestamp":1717422627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124001666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2666379124001666"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101498","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.01.26.525658","asserted-by":"object"}]},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncostatin M signaling drives cancer-associated skeletal muscle wasting","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101498","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101498"}}